DNTH vs DRI · rev $6.2M vs P/E 22, rev $12.08B
Dianthus Therapeutics Inc. (DNTH) versus Darden Restaurants Inc (DRI) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
DNTH currently screens at market cap $4.40B. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Not investment advice. Open the DNTH and DRI stock pages for the full models.
Not investment advice.